Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States

Background The prescription stimulants methylphenidate, amphetamine, and lisdexamfetamine are sympathomimetic drugs with therapeutic use. They are designated in the United States as Schedule II substances, defined by the 1970 Controlled Substances Act as having a “high potential for abuse”. Changing...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sneha M. Vaddadi, Nicholas J. Czelatka, Belsy D. Gutierrez, Bhumika C. Maddineni, Kenneth L. McCall, Brian J. Piper
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	PeerJ Inc. 2021-12-01
Edice:	PeerJ
Témata:	Amphetamine Methylphenidate Lisdexamfetamine Attention Deficit Hyperactivity Disorder Pharmacoepidemiology
On-line přístup:	https://peerj.com/articles/12619.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!